Navigation Links
Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007
Date:10/25/2007

t the human immune system to fight cancers, allergy and asthma disorders and to enhance the effectiveness of vaccines. Coley has established a pipeline of TLR Therapeutic product candidates currently advancing through clinical development with partners and has additional product candidates in preclinical development. Coley has product development, research and license agreements with Pfizer, sanofi-aventis, GlaxoSmithKline, Merck, Novartis Vaccines and the United States government. For further information on Coley Pharmaceutical Group please visit http://www.coleypharma.com.

Safe Harbor Statement

Certain statements in this news release concerning Coley's business are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Coley might make or by known or unknown risks and uncertainties, including, but not limited to: the early stage of product development; uncertainties as to the future success of ongoing and planned clinical trials; the risk that results from early stage clinical trials may not be indicative of results in later stage trials; the unproven safety and efficacy of products under development; intellectual property rights and litigation; competitive products; and other risks identified in Coley's filings with the Securities and Exchange Commission including, but not limited to, Coley's Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Consequently, no forward-looking statement can be guaranteed, and actual results may vary materially. Coley undertakes no obligation to publicly update forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.


'/>"/>
SOURCE Coley Pharmaceutical Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Seattle’s premier organic meal delivery service ( www.delicious-planet.com ) is ... Detox Program, Randi Carter, company founder and CEO reported today. ... ... – Seattle, WA) – Delicious Planet, Seattle’s premier organic meal ... the launch of its Delicious Planet Detox Program, Randi Carter, ...
(Date:12/15/2009)... Dec. 15 Comcast Corporation and Stand Up ... first-ever video-on-demand (VOD) initiative Stand Up 2 Cancer ... funds for innovative cancer research. Debuting exclusively on ... On Demand will feature an extraordinary library of ... of the world,s biggest stars and groups. ...
(Date:12/15/2009)... At a time when Americans spend over $50 billion ... Raymond Hall is theorizing a painful connection between conventional ... called Pillo1 ( www.pillo1.com ) to address the problem. ... John,s Medical Plaza Sleep Disorders Center showed that Pillo1 ... position and promotes increased time spent in REM (rapid ...
(Date:12/15/2009)... enable clean transition to new coding system. , ... ... 2009 -- The American Academy of Professional Coders ( AAPC ... training for health plans across the country beginning January. Developed ... coding and reimbursement experts, the on-site trainings are designed to ...
(Date:12/15/2009)... for consultations how will they get paid for patient care? ... terms. , ... Washington, DC (Vocus) ... eliminate consultation codes. These codes are what healthcare providers ... for a medical consultation, whether in a provider’s office or ...
Breaking Medicine News(10 mins):Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 5Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 3Health News:Medicare Eliminates Consultation Codes for Doctors 2
... study conducted by David Flora, PhD of the University of ... Chassin, PhD of Arizona State University//, says that parental alcoholism ... is generally known that children of alcoholics (COA's) suffer because ... time that a correlation has been established between alcohol abuse ...
... Palmer and his team from Southampton General Hospital, studied ... The research work is aimed at studying the environmental ... exposure to metal fume. ,Researchers found that ... low compared to the normal persons and an absence ...
... in serious trouble with regard to a trip made to ... halt, an eight-year-old health program for meant for the country’s ... Vision that operates the Nayab Health Services project for masseurs ... ,Helped by Britain's Naz Foundation International, Vision began a drop-in ...
... self-esteem and health of people, according to Penn State researchers. ... when compared to those who are happily married. Over a ... unhappy // marriages were interviewed. , ... studies, and demography said that dissolving a unhappy marriage would ...
... earlier research which said that fish was capable of scaling ... are present in fish do not serve to reduce cancer ... has however been // witnessed in the case of people ... ,Several trials have attempted to assess the effects of ...
... have proposed the administration of flu vaccine to all children ... to prevent the incidence of seasonal flu. The dreadful condition, ... winter, had claimed the valuable lives of over 1000 UK ... and Immunisation that addresses important medical issues and provides related ...
Other Medicine News:Health News:Pakistani Gays Land Themselves In Trouble 2
(Date:12/15/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that an overall survival benefit would ... surveyed European oncologists in their decision to prescribe ... treatment of breast cancer. ,, The new Special ... European Trends in Targeted Therapies in Breast Cancer: ...
(Date:12/15/2009)... Accumetrics, Inc., developer and marketer of the VerifyNow® ... for measuring an individual,s response to multiple antiplatelet ... the number of international and U.S. distribution agreements, ... significant capital financing that will take the company ... continued its commitment to creating a powerful, worldwide ...
(Date:12/14/2009)... LONDON, Dec. 14 The 2009 Frost ... the Ultrasound Market is conferred on SonoScape. The ... - the need for special features, pricing, and ... (HCU). The performance of this high-end colour ... high-end, cart-based echo ultrasound system. ,, ...
Breaking Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3MDS Reports Second Quarter 2009 Financial Results 48568 1MDS Reports Second Quarter 2009 Financial Results 48568 2MDS Reports Second Quarter 2009 Financial Results 48568 3MDS Reports Second Quarter 2009 Financial Results 48568 4MDS Reports Second Quarter 2009 Financial Results 48568 5MDS Reports Second Quarter 2009 Financial Results 48568 6MDS Reports Second Quarter 2009 Financial Results 48568 7MDS Reports Second Quarter 2009 Financial Results 48568 8MDS Reports Second Quarter 2009 Financial Results 48568 9MDS Reports Second Quarter 2009 Financial Results 48568 10MDS Reports Second Quarter 2009 Financial Results 48568 11MDS Reports Second Quarter 2009 Financial Results 48568 12MDS Reports Second Quarter 2009 Financial Results 48568 13MDS Reports Second Quarter 2009 Financial Results 48568 14MDS Reports Second Quarter 2009 Financial Results 48568 15MDS Reports Second Quarter 2009 Financial Results 48568 16MDS Reports Second Quarter 2009 Financial Results 48568 17MDS Reports Second Quarter 2009 Financial Results 48568 18MDS Reports Second Quarter 2009 Financial Results 48568 19Isis Pharmaceuticals to Present at Jefferies 3rd Annual Healthcare Conference 48563 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 2Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 3Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 4
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: ... for the,Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line Indolent (FIT) ... (ASH) 50th Annual Meeting by,Morschhauser, et al ... following Zevalin consolidation therapy for patients with,follicular ...
... SAN FRANCISCO, Dec. 7 The largest study ever ... help prevent deadly blood clots in patients with cancer ... on Sunday, December 7, at 9:30 a.m., during the ... in San Francisco, CA. Additional research being featured at ...
Other Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 2Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 3Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 4Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 6Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 7Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 8Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 9
... These revised charts incorporate the slight change ... the 10 Sloan letters derived from the ... eyes during the ETDRS study. The original ... examination of 234 eyes. In addition to ...
Created to simplify stereopsis screening in children. Based on principles of random dots. No glasses are necessary for this stereo test, and the child's eye movement can be easily observed....
... Stereo Cube is used to diagnose Stereo and ... use of polarized glasses. The test can ... stereopsis, visual attention, form and depth perception. The ... to 450 seconds of arc and is ideal ...
... simplify stereopsis screening in children. It is based ... Lang Stereotest II measures disparities: Moon and Star ... of arc plus monocularly visible star. In the ... smaller and less dense. This disparity is finer, ...
Medicine Products: